Cargando…
Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD)
Loneliness is a significant risk factor for substance use, however, impacts of treatments on loneliness are relatively unexplored. Living in a rural location is a greater risk factor for loneliness. This study examined data from a quasi-experimental study in rural Appalachia, comparing the effective...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602554/ https://www.ncbi.nlm.nih.gov/pubmed/36294057 http://dx.doi.org/10.3390/ijerph192013481 |
_version_ | 1784817347213656064 |
---|---|
author | Mills, Rosalina Zullig, Keith J. Theeke, Laurie A. Lander, Laura R. Hobbs, Gerry R. Herczyk, Johnathan Davis, Stephen M. |
author_facet | Mills, Rosalina Zullig, Keith J. Theeke, Laurie A. Lander, Laura R. Hobbs, Gerry R. Herczyk, Johnathan Davis, Stephen M. |
author_sort | Mills, Rosalina |
collection | PubMed |
description | Loneliness is a significant risk factor for substance use, however, impacts of treatments on loneliness are relatively unexplored. Living in a rural location is a greater risk factor for loneliness. This study examined data from a quasi-experimental study in rural Appalachia, comparing the effectiveness of Mindfulness-Based Relapse Prevention (MBRP) versus Treatment as Usual (TAU) among adults receiving MOUD in outpatient therapy. Our objective was to determine whether observed reductions in self-reported craving, anxiety, depression, and increased perceived mindfulness would also improve loneliness reports. Eighty participants (n = 35 MBRP; n = 45 TAU) were included in the analysis from a group-based Comprehensive Opioid Addiction Treatment program. Outcomes tracked included craving, anxiety, depression, mindfulness, and loneliness as measured by the Revised UCLA Loneliness Scale (R-UCLA). A linear mixed model ANOVA determined the significance of the treatments on changes in loneliness scores at baseline, 12 weeks, 24 weeks, and 36 weeks post-recruitment. Both groups reported significantly reduced loneliness over the course of the study (F = 16.07, p < 0.01), however there were no significant differences between groups. Loneliness was also significantly positively (p < 0.01) correlated with anxiety (0.66), depression (0.59), and craving (0.38), and significantly (p < 0.01) inversely correlated (−0.52) with mindfulness. Results suggest that participation in MOUD group-based outpatient therapy has the potential to diminish loneliness and associated poor psychological outcomes. Thus, it is possible that a more targeted intervention for loneliness would further diminish loneliness, which is important as loneliness is linked to risk for relapse. |
format | Online Article Text |
id | pubmed-9602554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96025542022-10-27 Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD) Mills, Rosalina Zullig, Keith J. Theeke, Laurie A. Lander, Laura R. Hobbs, Gerry R. Herczyk, Johnathan Davis, Stephen M. Int J Environ Res Public Health Article Loneliness is a significant risk factor for substance use, however, impacts of treatments on loneliness are relatively unexplored. Living in a rural location is a greater risk factor for loneliness. This study examined data from a quasi-experimental study in rural Appalachia, comparing the effectiveness of Mindfulness-Based Relapse Prevention (MBRP) versus Treatment as Usual (TAU) among adults receiving MOUD in outpatient therapy. Our objective was to determine whether observed reductions in self-reported craving, anxiety, depression, and increased perceived mindfulness would also improve loneliness reports. Eighty participants (n = 35 MBRP; n = 45 TAU) were included in the analysis from a group-based Comprehensive Opioid Addiction Treatment program. Outcomes tracked included craving, anxiety, depression, mindfulness, and loneliness as measured by the Revised UCLA Loneliness Scale (R-UCLA). A linear mixed model ANOVA determined the significance of the treatments on changes in loneliness scores at baseline, 12 weeks, 24 weeks, and 36 weeks post-recruitment. Both groups reported significantly reduced loneliness over the course of the study (F = 16.07, p < 0.01), however there were no significant differences between groups. Loneliness was also significantly positively (p < 0.01) correlated with anxiety (0.66), depression (0.59), and craving (0.38), and significantly (p < 0.01) inversely correlated (−0.52) with mindfulness. Results suggest that participation in MOUD group-based outpatient therapy has the potential to diminish loneliness and associated poor psychological outcomes. Thus, it is possible that a more targeted intervention for loneliness would further diminish loneliness, which is important as loneliness is linked to risk for relapse. MDPI 2022-10-18 /pmc/articles/PMC9602554/ /pubmed/36294057 http://dx.doi.org/10.3390/ijerph192013481 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mills, Rosalina Zullig, Keith J. Theeke, Laurie A. Lander, Laura R. Hobbs, Gerry R. Herczyk, Johnathan Davis, Stephen M. Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD) |
title | Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD) |
title_full | Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD) |
title_fullStr | Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD) |
title_full_unstemmed | Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD) |
title_short | Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD) |
title_sort | assessing loneliness among adults receiving outpatient treatment with medication for opioid use disorder (moud) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602554/ https://www.ncbi.nlm.nih.gov/pubmed/36294057 http://dx.doi.org/10.3390/ijerph192013481 |
work_keys_str_mv | AT millsrosalina assessinglonelinessamongadultsreceivingoutpatienttreatmentwithmedicationforopioidusedisordermoud AT zulligkeithj assessinglonelinessamongadultsreceivingoutpatienttreatmentwithmedicationforopioidusedisordermoud AT theekelauriea assessinglonelinessamongadultsreceivingoutpatienttreatmentwithmedicationforopioidusedisordermoud AT landerlaurar assessinglonelinessamongadultsreceivingoutpatienttreatmentwithmedicationforopioidusedisordermoud AT hobbsgerryr assessinglonelinessamongadultsreceivingoutpatienttreatmentwithmedicationforopioidusedisordermoud AT herczykjohnathan assessinglonelinessamongadultsreceivingoutpatienttreatmentwithmedicationforopioidusedisordermoud AT davisstephenm assessinglonelinessamongadultsreceivingoutpatienttreatmentwithmedicationforopioidusedisordermoud |